Emerging findings of regulatory function of IL-17 in the skin raise the possibility of potential negative impacts on skin barrier function, aggravated by the emergence of IL-22 as the pathogenic effector in fulminant skin inflammatory disorders with interference of IL-17R signaling. This evidence concerns the gene IL17RA and inflammatory skin disease.